Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
SCHWARTZ DAVID
   2. Issuer Name and Ticker or Trading Symbol
BIO RAD LABORATORIES INC [BIO, BIO.B] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chairman of the Board
(Last)
(First)
(Middle)
C/O BIO-RAD LABORATORIES, INC., 1000 ALFRED NOBEL DRIVE		 3. Date of Earliest Transaction (Month/Day/Year)
06/10/2010
(Street)

HERCULES, CA 94547		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Bio-Rad A Common Stock 02/12/2010   G V 274 D $ 0 1,404,588 (1) D  
Bio-Rad A Common Stock 04/29/2010   G V 8,086 D $ 0 825,208 (1) I By GRAT
Bio-Rad A Common Stock 04/29/2010   G V 8,086 D $ 0 825,208 (1) I by GRAT (spouse)
Bio-Rad A Common Stock               34,311 I By Trust
Bio-Rad B Common Stock 02/12/2010   G V 1,644 D $ 0 390,056 D  
Bio-Rad B Common Stock 06/10/2010   M   334 (2) A $ 0 390,390 D  
Bio-Rad B Common Stock               4,060,054 I By Blue Raven Partners, L.P. (3)
Bio-Rad B Common Stock               41,176 I By DANSA Partners Limited (4)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (5) 06/10/2010   M     334   (6)   (6) Bio-Rad B Common Stock 334 $ 0 1,336 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
SCHWARTZ DAVID
C/O BIO-RAD LABORATORIES, INC.
1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547		   X   X   Chairman of the Board  

Signatures

 David Schwartz   06/14/2010
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) In addition to the reported transaction, the following non-reportable transactions are reflected in the Amount of Securities Beneficially Owned Following Reported Transactions (Column 5): (1) on July 24, 2009, the reporting person and the reporting person's spouse each transferred 825,208 shares to an independent trustee of separate GRATS for the respective benefit of the grantors for estate planning purposes and, (2) on April 29, 2010, the reporting person and the reporting person's spouse each received 90,661 Class A shares as a distribution from their separate 2008 GRATs to their direct beneficial holdings.
(2) Shares of Class B common stock acquired on the vesting of restricted stock units.
(3) The shares are held by a limited partnership of which the reporting person is a limited and general partner.
(4) The shares are held by a limited partnership of which the reporting person is a general partner.
(5) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock.
(6) The restriced stock units vest in five equal annual installments beginning June 10, 2010.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.